Cary Street Partners Investment Advisory’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-600	Closed	-$19K	–	1410
2023 Q3	$19K	Hold	600	–	–	﹤0.01%	1143
2023 Q2	$24.5K	Hold	600	–	–	﹤0.01%	994
2023 Q1	$22.4K	Hold	600	–	–	﹤0.01%	944
2022 Q4	$20.9K	Buy	+600	New	+$20.9K	﹤0.01%	964